Quest for Research Freedom Fuels African Biotech Boom

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

Written byLinda Nordling
| 6 min read
Women wearing a lab coat and mask uses a computer in a lab

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

ABOVE: Staff at genomics company 54gene work in a lab at the company’s Nigerian headquarters.
54GENE

Returning to his native Ghana after a postdoc in the United Kingdom, Yaw Bediako thought he had his future pretty much mapped out. “I felt everything was leading me to the usual model of academic research—full professor before I’m forty-five, with my own research group, a good grant portfolio, and students working for me,” the immunologist says.

But soon after his return in 2019, he began to feel stifled. Although his workplace, the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) in Accra, was one of the country’s foremost research institutions, its parent institution, the University of Ghana, had what Bediako experienced as cumbersome bureaucracy ill-suited for a hungry young scientist. And he describes a “crushing pressure” to obtain foreign research grants, which he says he needed to supplement his meager university ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies